| # | Drug | Count |
|---|---|---|
| 0 | PEGFILGRASTIM | 277 |
| 1 | BUPRENORPHINE | 48 |
| 2 | NICOTINE | 46 |
| 3 | ESTRADIOL | 35 |
| 4 | ERGOCALCIFEROL | 24 |
| 5 | METHYLPHENIDATE | 24 |
| 6 | OXYBUTYNIN | 19 |
| 7 | ASPIRIN | 17 |
| 8 | LIDOCAINE | 16 |
| 9 | ASPIRIN 325 MG | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM | 1 | 0.0357 |
| 1 | PEGFILGRASTIM | 277 | 0.0231 |
| 2 | MENTHOL, METHYL SALICYLATE | 7 | 0.0116 |
| 3 | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 4 | 0.0101 |
| 4 | NORELGESTROMIN AND ETHINYL ESTRADIOL | 9 | 0.0048 |
| 5 | SODIUM CARBONATE | 1 | 0.0043 |
| 6 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | 4 | 0.0042 |
| 7 | TIRBANIBULIN | 1 | 0.0040 |
| 8 | ADALIMUMAB-AACF | 1 | 0.0030 |
| 9 | MENTHOL AND METHYL SALICYLATE | 2 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Leukocyte Growth Factor [EPC] | 278 |
| 1 | Cholinergic Nicotinic Agonist [EPC] | 61 |
| 2 | Estrogen [EPC] | 50 |
| 3 | Partial Opioid Agonist [EPC] | 48 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 5 | Central Nervous System Stimulant [EPC] | 27 |
| 6 | Provitamin D2 Compound [EPC] | 24 |
| 7 | Benzodiazepine [EPC] | 23 |
| 8 | Corticosteroid [EPC] | 21 |
| 9 | Cholinergic Muscarinic Antagonist [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Leukocyte Growth Factor [EPC] | 278 | 0.0019 |
| 2 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 3 | Cholinergic Nicotinic Agonist [EPC] | 61 | 0.0010 |
| 4 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 5 | Cytolytic Agent [EPC] | 2 | 0.0009 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 7 | Provitamin D2 Compound [EPC] | 24 | 0.0008 |
| 8 | Interferon gamma [EPC] | 1 | 0.0007 |
| 9 | Endoglycosidase [EPC] | 1 | 0.0005 |